Expert Insights
Targeting Huntington’s Disease: Current and Emerging Options
Release Date: December 30, 2021
Expiration Date: December 29, 2022
CE/CME Credit Hours: 1.00
Pharmacology Credit Hours: 1.00
Begin »
Program Overview
Program Description
Huntington’s disease (HD) is an inherited, progressive, neurodegenerative disorder that results in cognitive impairment, psychiatric/behavioral changes, and impaired motor function, including characteristic chorea. Although trials investigating disease-modifying therapies are in progress, there is currently no cure for HD, and the average life expectancy is 15-20 years after diagnosis. Disease management focuses on alleviating symptoms, maximizing function, and optimizing quality of life. In this activity, Victor W. Sung, MD, addresses key topics in the management of adult-onset HD, including early recognition and diagnosis, current and emerging therapies, advances in chorea treatments, and the role of primary care clinicians in multidisciplinary management.
Format
eNewsletter with interactive benchmarking and audio commentary
Learning Objectives
After completing this activity, participants should be better able to:
- Describe the potential motor, cognitive, and psychiatric signs and symptoms across the spectrum of HD
- Screen patients for early signs and symptoms of HD
- Summarize current and emerging therapeutic options for management of chorea in HD
Target Audience
NPs and PAs
Faculty
Victor W. Sung, MD
- Associate Professor
- Department of Neurology
- Division of Movement Disorders
- Clinic Director
- Huntington's Disease Clinic/HDSA Center of Excellence
- University of Alabama at Birmingham
- Birmingham, Alabama
Details
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP Course Advisor: Jessie Gibson, PhD, RN, AGPCNP-BC, University of Virginia School of Nursing, Charlottesville, Virginia
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until December 29, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA Course Advisor: Mark Christiansen, PhD, PA-C, University of the Pacific, Sacramento, California
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Teva Pharmaceuticals.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Gibson: contracted research/consulting fees/fees for non-CE/CME services: Teva Pharmaceuticals.
Dr Sung: consulting fees: Teva Pharmaceuticals.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Gibson as noted above.
Participants wishing to earn CE/CME credit must:
- Review the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: December 30, 2021
Expiration date: December 29, 2022
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 104121TV